PALBOCICLIB ISETHIONATE: 50 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
50
Total FAERS Reports
2 (4.0%)
Deaths Reported
12
Hospitalizations
50
As Primary/Secondary Suspect
First Report: 201609 · Latest Report: 20231110
What Are the Most Common PALBOCICLIB ISETHIONATE Side Effects?
#1 Most Reported
Neutropenia
19 reports (38.0%)
#2 Most Reported
Malignant neoplasm progression
11 reports (22.0%)
#3 Most Reported
Hepatitis
9 reports (18.0%)
All PALBOCICLIB ISETHIONATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 19 | 38.0% | 0 | 3 |
| Malignant neoplasm progression | 11 | 22.0% | 0 | 0 |
| Cytopenia | 9 | 18.0% | 0 | 0 |
| Hepatitis | 9 | 18.0% | 0 | 0 |
| Diarrhoea | 6 | 12.0% | 1 | 5 |
| Metastases to bone | 6 | 12.0% | 0 | 0 |
| Breast cancer metastatic | 5 | 10.0% | 0 | 0 |
| Metastases to liver | 5 | 10.0% | 0 | 0 |
| Syncope | 5 | 10.0% | 0 | 5 |
| White blood cell count decreased | 5 | 10.0% | 1 | 3 |
Who Reports PALBOCICLIB ISETHIONATE Side Effects? Age & Gender Data
Gender: 92.0% female, 8.0% male. Average age: 58.4 years. Most reports from: CA. View detailed demographics →
Is PALBOCICLIB ISETHIONATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 1 | 0 | 0 |
| 2017 | 2 | 0 | 0 |
| 2018 | 2 | 0 | 0 |
| 2019 | 10 | 0 | 5 |
| 2020 | 2 | 0 | 0 |
| 2022 | 6 | 2 | 3 |
| 2023 | 3 | 0 | 3 |
What Is PALBOCICLIB ISETHIONATE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 18 |
| Breast cancer metastatic | 9 |
| Breast cancer | 6 |
| Oestrogen receptor positive breast cancer | 5 |
Official FDA Label for PALBOCICLIB ISETHIONATE
Official prescribing information from the FDA-approved drug label.